During the past decade, CAPED Centro Avancado Pesquisa e Diagnostica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CAPED Centro Avancado Pesquisa e Diagnostica" are "Heart Failure With Preserved Ejection Fraction" (2 trials), "Heart Failure" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "CAPED Centro Avancado Pesquisa e Diagnostica" in a lesser frequency.

Most popular intervention types in "CAPED Centro Avancado Pesquisa e Diagnostica" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "LY3540378" (1 trials) and "Tirzepatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "CAPED Centro Avancado Pesquisa e Diagnostica" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CAPED Centro Avancado Pesquisa e Diagnostica". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in CAPED Centro Avancado Pesquisa e Diagnostica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CAPED Centro Avancado Pesquisa e Diagnostica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".